相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。IDH1 Mutations Alter Citric Acid Cycle Metabolism and Increase Dependence on Oxidative Mitochondrial Metabolism
Alexandra R. Grassian et al.
CANCER RESEARCH (2014)
Proto-Oncogenic Role of Mutant IDH2 in Leukemia Initiation and Maintenance
Lev M. Kats et al.
CELL STEM CELL (2014)
Clonal Tracing of Sox9+ Liver Progenitors in Mouse Oval Cell Injury
Branden D. Tarlow et al.
HEPATOLOGY (2014)
Cancer-associated Isocitrate Dehydrogenase 1 (IDH1) R132H Mutation and D-2-Hydroxyglutarate Stimulate Glutamine Metabolism under Hypoxia
Zachary J. Reitman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Biochemical, Cellular, and Biophysical Characterization of a Potent Inhibitor of Mutant Isocitrate Dehydrogenase IDH1
Mindy I. Davis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Tracing Compartmentalized NADPH Metabolism in the Cytosol and Mitochondria of Mammalian Cells
Caroline A. Lewis et al.
MOLECULAR CELL (2014)
Combined Hepatocellular-Cholangiocarcinoma: A Population-Level Analysis of an Uncommon Primary Liver Tumor
Mattia Garancini et al.
LIVER TRANSPLANTATION (2014)
Combined Hepatocellular Cholangiocarcinoma: A Case Report and Review of Literature
Shailender Singh et al.
DIGESTIVE DISEASES AND SCIENCES (2013)
Modeling Pathogenesis of Primary Liver Cancer in Lineage-Specific Mouse Cell Types
Agnes Holczbauer et al.
GASTROENTEROLOGY (2013)
Integrative Molecular Analysis of Intrahepatic Cholangiocarcinoma Reveals 2 Classes That Have Different Outcomes
Daniela Sia et al.
GASTROENTEROLOGY (2013)
What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer
Julie-Aurore Losman et al.
GENES & DEVELOPMENT (2013)
Cancer-associated IDH2 mutants drive an acute myeloid leukemia that is susceptible to Brd4 inhibition
Chong Chen et al.
GENES & DEVELOPMENT (2013)
Robust cellular reprogramming occurs spontaneously during liver regeneration
Kilangsungla Yanger et al.
GENES & DEVELOPMENT (2013)
Hepatocyte nuclear factor 4 alpha deletion promotes diethylnitrosamine-induced hepatocellular carcinoma in rodents
Chad Walesky et al.
HEPATOLOGY (2013)
Molecular profiling of cholangiocarcinoma shows potential for targeted therapy treatment decisions
Jesse S. Voss et al.
HUMAN PATHOLOGY (2013)
Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers
Waraporn Chan-on et al.
NATURE GENETICS (2013)
Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas
Yuchen Jiao et al.
NATURE GENETICS (2013)
Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas
P. Wang et al.
ONCOGENE (2013)
Mouse model of intrahepatic cholangiocarcinoma validates FIG-ROS as a potent fusion oncogene and therapeutic target
Anna Saborowski et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
(R)-2-Hydroxyglutarate Is Sufficient to Promote Leukemogenesis and Its Effects Are Reversible
Julie-Aurore Losman et al.
SCIENCE (2013)
An Inhibitor of Mutant IDH1 Delays Growth and Promotes Differentiation of Glioma Cells
Dan Rohle et al.
SCIENCE (2013)
Targeted Inhibition of Mutant IDH2 in Leukemia Cells Induces Cellular Differentiation
Fang Wang et al.
SCIENCE (2013)
KrasG12D and p53 Mutation Cause Primary intrahepatic Cholangiocarcinoma
Michael R. O'Dell et al.
CANCER RESEARCH (2012)
D-2-hydroxyglutarate produced by mutant IDH1 perturbs collagen maturation and basement membrane function
Masato Sasaki et al.
GENES & DEVELOPMENT (2012)
Isocitrate dehydrogenase 1 and 2 mutations in cholangiocarcinoma
Benjamin R. Kipp et al.
HUMAN PATHOLOGY (2012)
Cholangiocarcinomas can originate from hepatocytes in mice
Biao Fan et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
IDH mutation impairs histone demethylation and results in a block to cell differentiation
Chao Lu et al.
NATURE (2012)
Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation
Peppi Koivunen et al.
NATURE (2012)
IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype
Sevin Turcan et al.
NATURE (2012)
IDH1(R132H) mutation increases murine haematopoietic progenitors and alters epigenetics
Masato Sasaki et al.
NATURE (2012)
Frequent Mutation of Isocitrate Dehydrogenase (IDH)1 and IDH2 in Cholangiocarcinoma Identified Through Broad-Based Tumor Genotyping
Darrell R. Borger et al.
ONCOLOGIST (2012)
Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent Dioxygenases
Wei Xu et al.
CANCER CELL (2011)
The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-Hydroxyglutarate
Patrick S. Ward et al.
CANCER CELL (2010)
Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
Maria E. Figueroa et al.
CANCER CELL (2010)
Organogenesis and Development of the Liver
Karim Si-Tayeb et al.
DEVELOPMENTAL CELL (2010)
Genetics of Biliary Tract Cancers and Emerging Targeted Therapies
Aram F. Hezel et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Lenny Dang et al.
NATURE (2009)
Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach
Lars Zender et al.
CELL (2006)
分享论文
